(Q39499020)

English

Phase II trial of combination bevacizumab and temsirolimus in the treatment of recurrent or persistent endometrial carcinoma: a Gynecologic Oncology Group study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Phase II trial of combination bevacizumab and temsirolimus in the treatment of recurrent or persistent endometrial carcinoma: a Gynecologic Oncology Group study (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

phase II clinical trial

0 references

1 reference

based on heuristic

inferred from title

endometrial carcinoma

1 reference

based on heuristic

inferred from title

gynecologic oncology

1 reference

based on heuristic

inferred from title

9

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Jeanne M. Schilder

8

object named as

Jeanne M Schilder

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Carol Aghajanian

12

object named as

Carol Aghajanian

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

author name string

Edwin A Alvarez

1

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

William E Brady

2

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Joan L Walker

3

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Jacob Rotmensch

4

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Xun C Zhou

5

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

James E Kendrick

6

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

S Diane Yamada

7

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Charles R Harrison

10

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Kathleen N Moore

11

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

language of work or name

0 references

publication date

20 December 2012

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Gynecologic Oncology

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

129

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

22-27

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.022

7 January 2021

Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.022

7 January 2021

Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.022

7 January 2021

High frequency of coexistent mutations of PIK3CA and PTEN genes in endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.022

7 January 2021

Phase II study of temsirolimus in women with recurrent or metastatic endometrial cancer: a trial of the NCIC Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.022

7 January 2021

Phase II trial of bevacizumab in recurrent or persistent endometrial cancer: a Gynecologic Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.022

7 January 2021

A method for utilizing co-primary efficacy outcome measures to screen regimens for activity in two-stage Phase II clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.022

7 January 2021

Hallmarks of Cancer: The Next Generation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.022

7 January 2021

A phase II trial of thalidomide in patients with refractory endometrial cancer and correlation with angiogenesis biomarkers: a Gynecologic Oncology Group study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.022

7 January 2021

Phosphorylated KDR expression in endometrial cancer cells relates to HIF1α/VEGF pathway and unfavourable prognosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.022

7 January 2021

PI3K/AKT/mTOR Pathway in Angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.022

7 January 2021

A phase 2 study of the oral mammalian target of rapamycin inhibitor, everolimus, in patients with recurrent endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.022

7 January 2021

Cardiovascular disease is the leading cause of death among endometrial cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.022

7 January 2021

Temsirolimus and bevacizumab, or sunitinib, or interferon alfa and bevacizumab for patients with advanced renal cell carcinoma (TORAVA): a randomised phase 2 trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.022

7 January 2021

Randomized phase II trial of sorafenib with temsirolimus or tipifarnib in untreated metastatic melanoma (S0438).

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.022

7 January 2021

Temsirolimus and rituximab in patients with relapsed or refractory mantle cell lymphoma: a phase 2 study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.022

7 January 2021

Identifiers

10.1016/J.YGYNO.2012.12.022

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39499020&oldid=2046271842"